Stock Buybacks (Quarterly) Chart

View Stock Buybacks (Quarterly) for ISRG.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Buybacks (Quarterly) Chart
Start Trial

Historical Stock Buybacks (Quarterly) Data

View and export this data back to 2000. Start Trial.
Date Value
June 30, 2026 254.70M
March 31, 2026 1.001B
December 31, 2025 124.40M
September 30, 2025 1.823B
June 30, 2025 131.60M
March 31, 2025 -134.30M
December 31, 2024 -61.90M
September 30, 2024 -115.60M
June 30, 2024 -71.50M
March 31, 2024 -180.40M
December 31, 2023 22.20M
September 30, 2023 -77.40M
June 30, 2023 -74.60M
March 31, 2023 249.80M
December 31, 2022 955.60M
September 30, 2022 918.00M
June 30, 2022 473.50M
March 31, 2022 26.50M
December 31, 2021 -31.70M
September 30, 2021 -91.10M
June 30, 2021 -69.70M
March 31, 2021 -84.00M
December 31, 2020 -6.60M
September 30, 2020 -113.90M
June 30, 2020 -62.70M
Date Value
March 31, 2020 8.70M
December 31, 2019 -67.10M
September 30, 2019 -16.60M
June 30, 2019 169.20M
March 31, 2019 -88.80M
December 31, 2018 -37.00M
September 30, 2018 -64.70M
June 30, 2018 -48.70M
March 31, 2018 -86.20M
December 31, 2017 240.10M
September 30, 2017 -85.20M
June 30, 2017 -127.30M
March 31, 2017 1.831B
December 31, 2016 3.90M
September 30, 2016 -101.90M
June 30, 2016 -189.70M
March 31, 2016 -250.70M
December 31, 2015 17.10M
September 30, 2015 -101.00M
June 30, 2015 -28.00M
March 31, 2015 -65.50M
December 31, 2014 -107.60M
September 30, 2014 -85.50M
June 30, 2014 975.80M
March 31, 2014 -66.30M

Stock Buyback Definition

Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.

Read full definition.

Stock Buybacks (Quarterly) Range, Past 5 Years

View Stock Buybacks (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Buybacks (Quarterly) Benchmarks

View Stock Buybacks (Quarterly) Benchmarks
Start Trial
Stryker Corp. 0.00
Zimmer Biomet Holdings, Inc. 250.60M
Abbott Laboratories 1.042B
Boston Scientific Corp. 1.995B
Globus Medical, Inc. 125.09M